Slide

Delivering drug discovery via our unique display technology

Peptide
Discovery

PLAY VIDEO FIND OUT MORE FUNCTIONAL SCREENING DNA Encoded
Peptide Display
Watch now
drive10

Our Technology

Orbit develop and apply innovative drug discovery platforms defined by a unique peptide display engine that deliver novel, functional, biologically relevant peptide therapeutic leads

Peptide leads are key starting points for the development of peptide, peptidomimetic and small molecule therapeutics as well as bioconjugates for cell targeting and cargo delivery

We offer services for the high throughput screening of chemical space and perform affinity screening and functional screening using both bead based technologies and microfuidics.

Orbits mission is to offer our Partners solutions to identify therapeutic candidates by adopting high throughput affinity and functional screening.

iq-image
iq-image
iq-image
Affinity screening

A bead based peptide display engine allows for faster peptide discovery by binding affinity

Functional Screening

The ability to display high peptide copy number allows discovery of functional peptides in primary screens

Targets

The Orbit platform is target agnostic giving access to cell surface receptors, notably GPCRs and ion channels

Single cell

The Orbit platform can distinguish a response from single cells

High throughput

Use of Microfluidics to Miniaturise library production and cellular screening

Establishing a new standard

Orbit works with both industry and academic Partners to identify hits for existing and novel drug targets where therapeutic peptides can establish a new standard of care.  

drive10
iq-image

Slide

Find out how Orbit can help you with peptide discovery

iq-image